A total of 30 adult patients with GERD receiving proton pump inhi

A total of 30 adult patients with GERD receiving proton pump inhibitor (PPI) therapy were assessed. In both the control and intervention groups, a pretest consisting of 23 questions assessed patients’ knowledge regarding GERD and lifestyle

modifications. A presurvey consisting of eight questions assessed patients’ current behaviors associated with GERD management using both lifestyle modifications and PPIs. The intervention group also received approximately 10 minutes of education on lifestyle modifications. A posttest and postsurvey were given 8 to 12 weeks after the initial session to both groups. Main outcome measures included change in test score for patients in the control versus intervention groups. find more Outcomes measured on the pre- and postsurvey included source of heartburn information/education, smoking status,

trigger foods eaten weekly, frequency of monthly heartburn episodes, and PPI adherence.

Results: The average change in test scores was 1.33 and 2.73 in the control and intervention groups, respectively (P = 0.11; two-sample t test). The frequency of monthly heartburn episodes increased postsurvey in the control group; however, the frequency of monthly episodes decreased in the intervention group. this website For the presurvey, no patients reported ever having received GERD education from a pharmacist. For the postsurvey, all 15 patients in the intervention group stated that they had received education from a pharmacist.

Conclusion: The intervention group patients had higher mean change in test scores compared with the control group, although this difference did not reach statistical significance. The failure to achieve statistical significance may have resulted from the small sample size. The pharmacist-patient interaction improved patient knowledge and some behaviors made in GERD management and symptom reduction. J Am Pharm Assoc. 2009;49:544-548. doi:10.1331/JAPhA.2009.08004″
“Laparoscopic Roux-en-Y gastric bypass (LRYGB) is the most commonly

performed bariatric/metabolic operation in Europe. Different treatment options for the management of gastrojejunal (GJ) leaks following LRYGB have been published. We looked at our own experience with GJ leaks after 645 consecutive LRYGB operations and reviewed the literature with focus on the use of fibrin sealant and self-expandable metal buy CRT0066101 stents as treatment options. Patient data were prospectively collected in the hospital’s database for bariatric patients. All patients with confirmed GJ leaks were reviewed. Patients with GJ leaks were actively treated by a combination of laparoscopic drainage and endoscopic fibrin sealant injections and/or stenting. Six patients (0.93 %) have been treated for GJ leaks. All leaks were successfully treated and there was no leak-related mortality. The mean (SD) time for closure of the leaks and length of hospital stay was 19.5 days (6.2) and 23.2 days (3.7).

Comments are closed.